Who and/or what is AbbVie. All of a sudden it appears on the CP chat board. Is this a foreign Pharma company?? a Biotech?? A fly by night Pharma with one drug?? What is it??
Anonymous
Guest
Anonymous
Guest
Abbvie was spun off from Abbott Labs on Jan 1. It is the pharma half, whereas Abbott is now nutrition, medical devices, and generics.
Anonymous
Guest
Anonymous
Guest
Thanks. AbbVie sounds like a company from India. Is that where they're based?
Anonymous
Guest
Anonymous
Guest
Thanks. AbbVie sounds like a company from India. Is that where they're based?
R&D will be based there or China after the layoffs are finished.
Anonymous
Guest
Anonymous
Guest
For you morons out there......
AbbVie Inc., a research-based pharmaceuticals company, with 21,000 full-time employees engages in the discovery, development, manufacture, and sale of a line of pharmaceuticals and biologics worldwide. The companys principal products are HUMIRA for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, juvenile idiopathic arthritis, and Crohn's disease as well as ulcerative colitis, and axial spondyloarthritis; Kaletra used in the treatment of HIV infection; Lupron used for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia; Synagis, a syncytial virus prevention product used to protect infants from severe respiratory disease; AndroGel for the treatment of adult males who have low testosterone; sevoflurane, an anesthesia product; Zemplar for the prevention and treatment of secondary hyperparathyroidism associated with stage 3, 4, or 5 chronic kidney disease; Synthroid used for the treatment of hypothyroidism; Creon for the treatment of pancreatic exocrine insufficiency; and TriCor, Trilipix, Simcor, and Niaspan for the treatment of dyslipidemia. It also has a pipeline of new medicines consisting of approximately 20 compounds or indications in Phase II or Phase III development in medical specialties, such as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. In addition, the company offers other products, such as Duodopa, a levodopa-carbidopa intestinal gel for the treatment of advanced Parkinson's disease. AbbVie Inc. sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie Inc. is a subsidiary of Abbott Laboratories. AbbVie Inc. operates independently of Abbott Laboratories as of January 01, 2013.
AbbVie Inc., a research-based pharmaceuticals company, with 21,000 full-time employees engages in the discovery, development, manufacture, and sale of a line of pharmaceuticals and biologics worldwide. The companys principal products are HUMIRA for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, juvenile idiopathic arthritis, and Crohn's disease as well as ulcerative colitis, and axial spondyloarthritis; Kaletra used in the treatment of HIV infection; Lupron used for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia; Synagis, a syncytial virus prevention product used to protect infants from severe respiratory disease; AndroGel for the treatment of adult males who have low testosterone; sevoflurane, an anesthesia product; Zemplar for the prevention and treatment of secondary hyperparathyroidism associated with stage 3, 4, or 5 chronic kidney disease; Synthroid used for the treatment of hypothyroidism; Creon for the treatment of pancreatic exocrine insufficiency; and TriCor, Trilipix, Simcor, and Niaspan for the treatment of dyslipidemia. It also has a pipeline of new medicines consisting of approximately 20 compounds or indications in Phase II or Phase III development in medical specialties, such as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. In addition, the company offers other products, such as Duodopa, a levodopa-carbidopa intestinal gel for the treatment of advanced Parkinson's disease. AbbVie Inc. sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie Inc. is a subsidiary of Abbott Laboratories. AbbVie Inc. operates independently of Abbott Laboratories as of January 01, 2013.
Anonymous
Guest
Anonymous
Guest
For you morons out there......
AbbVie Inc., a research-based pharmaceuticals company, with 21,000 full-time employees engages in the discovery, development, manufacture, and sale of a line of pharmaceuticals and biologics worldwide. The company’s principal products are HUMIRA for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, juvenile idiopathic arthritis, and Crohn's disease as well as ulcerative colitis, and axial spondyloarthritis; Kaletra used in the treatment of HIV infection; Lupron used for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia; Synagis, a syncytial virus prevention product used to protect infants from severe respiratory disease; AndroGel for the treatment of adult males who have low testosterone; sevoflurane, an anesthesia product; Zemplar for the prevention and treatment of secondary hyperparathyroidism associated with stage 3, 4, or 5 chronic kidney disease; Synthroid used for the treatment of hypothyroidism; Creon for the treatment of pancreatic exocrine insufficiency; and TriCor, Trilipix, Simcor, and Niaspan for the treatment of dyslipidemia. It also has a pipeline of new medicines consisting of approximately 20 compounds or indications in Phase II or Phase III development in medical specialties, such as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. In addition, the company offers other products, such as Duodopa, a levodopa-carbidopa intestinal gel for the treatment of advanced Parkinson's disease. AbbVie Inc. sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie Inc. is a subsidiary of Abbott Laboratories. AbbVie Inc. operates independently of Abbott Laboratories as of January 01, 2013.
WAAAAY too many reps associated with the above products. Territories too small, too many stepping over each other, etc. Be prepared in all products for a humongous reorg that will address this and result in a tremendous downsizing of primary care and specialty sales forces. It will be sooner not later. The supposed "pipeline" is too far down the road to absorb many of these surplus reps. ZS has it all laid out; it is just a matter of the phone calls and announcements being made. Complete collapse of top sales management positions as well. Random, legally sanitized criteria established to avoid any subjective claims of bias for those eliminated.
Anonymous
Guest
Anonymous
Guest
Anonymous
Guest
WAAAAY too many reps associated with the above products. Territories too small, too many stepping over each other, etc. Be prepared in all products for a humongous reorg that will address this and result in a tremendous downsizing of primary care and specialty sales forces. It will be sooner not later. The supposed "pipeline" is too far down the road to absorb many of these surplus reps. ZS has it all laid out; it is just a matter of the phone calls and announcements being made. Complete collapse of top sales management positions as well. Random, legally sanitized criteria established to avoid any subjective claims of bias for those eliminated.
but Solvay reps are safe. LMFAO!!!!!
Anonymous
Guest
Anonymous
Guest
but Solvay reps are safe. LMFAO!!!!!
Will the reorg be before or after the NSM??
Anonymous
Guest
Anonymous
Guest
Will the reorg be before or after the NSM??
I don't know. But I do remember the TAP reorg..... brought everyone in and sent them to two different meeting rooms. Ugh.
Anonymous
Guest
Anonymous
Guest
For you morons out there......
AbbVie Inc., a research-based pharmaceuticals company, with 21,000 full-time employees engages in the discovery, development, manufacture, and sale of a line of pharmaceuticals and biologics worldwide. The company’s principal products are HUMIRA for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, juvenile idiopathic arthritis, and Crohn's disease as well as ulcerative colitis, and axial spondyloarthritis; Kaletra used in the treatment of HIV infection; Lupron used for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia; Synagis, a syncytial virus prevention product used to protect infants from severe respiratory disease; AndroGel for the treatment of adult males who have low testosterone; sevoflurane, an anesthesia product; Zemplar for the prevention and treatment of secondary hyperparathyroidism associated with stage 3, 4, or 5 chronic kidney disease; Synthroid used for the treatment of hypothyroidism; Creon for the treatment of pancreatic exocrine insufficiency; and TriCor, Trilipix, Simcor, and Niaspan for the treatment of dyslipidemia. It also has a pipeline of new medicines consisting of approximately 20 compounds or indications in Phase II or Phase III development in medical specialties, such as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. In addition, the company offers other products, such as Duodopa, a levodopa-carbidopa intestinal gel for the treatment of advanced Parkinson's disease. AbbVie Inc. sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie Inc. is a subsidiary of Abbott Laboratories. AbbVie Inc. operates independently of Abbott Laboratories as of January 01, 2013.
So please 'splain to me, is it a subsidiary or isn't it? Last two sentences seem to contradict eachother. Perhaps this was meant to confuse potential shareholders? It is either another administrative error or a misleading statement. Was this a press release?
Anonymous
Guest
Anonymous
Guest
For you morons out there......
AbbVie Inc., a research-based pharmaceuticals company, with 21,000 full-time employees engages in the discovery, development, manufacture, and sale of a line of pharmaceuticals and biologics worldwide. The company’s principal products are HUMIRA for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis, juvenile idiopathic arthritis, and Crohn's disease as well as ulcerative colitis, and axial spondyloarthritis; Kaletra used in the treatment of HIV infection; Lupron used for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the preoperative treatment of patients with anemia; Synagis, a syncytial virus prevention product used to protect infants from severe respiratory disease; AndroGel for the treatment of adult males who have low testosterone; sevoflurane, an anesthesia product; Zemplar for the prevention and treatment of secondary hyperparathyroidism associated with stage 3, 4, or 5 chronic kidney disease; Synthroid used for the treatment of hypothyroidism; Creon for the treatment of pancreatic exocrine insufficiency; and TriCor, Trilipix, Simcor, and Niaspan for the treatment of dyslipidemia. It also has a pipeline of new medicines consisting of approximately 20 compounds or indications in Phase II or Phase III development in medical specialties, such as immunology, renal care, hepatitis C, women's health, oncology, and neuroscience, including multiple sclerosis and Alzheimer's disease. In addition, the company offers other products, such as Duodopa, a levodopa-carbidopa intestinal gel for the treatment of advanced Parkinson's disease. AbbVie Inc. sells its products directly to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers. The company was incorporated in 2012 and is based in North Chicago, Illinois. AbbVie Inc. is a subsidiary of Abbott Laboratories. AbbVie Inc. operates independently of Abbott Laboratories as of January 01, 2013.
So, what's your point?